ArticleAnnals of hematology2023

Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia.

Wenbing Duan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.